Mobarak S. AlShahrani

National Pharmacovigilance Center Director
Saudi Food and Drugs Authority, Saudi Arabia

Poster(s):

• (A-263) A Two-Year Review of Adverse Drug Events (ADEs) in Saudi Arabia: Trends and Pharmacovigilance Insights from 2023-2024
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-180) Review of Depression Signal Discovered Following Spontaneous Reports of Injectable Anti Diabetics (Semaglutide and Tirzepatide)
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET